Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Shares Outstanding (Weighted Average) (2016 - 2026)

InflaRx's Shares Outstanding (Weighted Average) history spans 10 years, with the latest figure at $10.2 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 18.77% to $10.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.2 million, a 18.77% increase, with the full-year FY2025 number at $10.1 million, down 83.96% from a year prior.
  • Shares Outstanding (Weighted Average) hit $10.2 million in Q1 2026 for InflaRx, up from $10.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for IFRX hit a ceiling of $63.0 million in Q4 2024 and a floor of $330.79 in Q2 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $14.5 million across 5 years, with a median of $7.7 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 43.82% in 2023 and later plummeted 83.96% in 2025.
  • Tracing IFRX's Shares Outstanding (Weighted Average) over 5 years: stood at $45.6 million in 2022, then rose by 29.61% to $59.1 million in 2023, then rose by 6.51% to $63.0 million in 2024, then plummeted by 83.96% to $10.1 million in 2025, then increased by 0.58% to $10.2 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for IFRX at $10.2 million in Q1 2026, $10.1 million in Q4 2025, and $9.5 million in Q3 2025.